E’ville Biz: Grifols completes renovation, Adamas gets FDA Approval, Grocery Outlet raises $1M, RedAwning Startup
Four Emeryville companies have grabbed headlines for different reasons over the past month.
Grifols USA has been busy renovating their campus that they acquired from Novartis in 2013 as part of a business unit acquisition. The $80 million project was recently profiled by the SF Business Times.
A small Emeryville startup called RedAwning just received substantial venture capital that should help them build on their business niche of providing a ‘hotel polish’ to Airbnb type home rentals.
Grocery Outlet, which moved their headquarters to a former Bayer office on Hollis in 2013, announced they raised more than $1 million to feed families in need as part of their annual Independence from Hunger program.
Out for blood: Chiron legacy leads Spanish company to $80M East Bay project
By Ron Leuty
An East Bay structure built by biotech legend Cetus Corp., bought by Chiron Corp., leased by Bayer and held by Novartis AG, has new life under a quiet Spanish company that could use it to unlock a new generation of tests for detecting diseases and making blood safer.
Grifols SA’s $80 million renovation of the four-story, 100,000-square-foot consolidated manufacturing facility in Emeryville is significant because of where it sits in Grifols’ process of making recombinant proteins. Those substances act as antigens, which induce an immune response, providing a way to test plasma that is essential to treating patients with hemophilia, immune deficiencies and other blood-borne conditions.
Read More on SF Business Times →
(paywall may apply)
Grocery Outlet Raises $1 Million For Local Food Banks
Grocery Outlet Bargain Market’s 7th Annual Independence from Hunger® (IFH) campaign has raised more than $1 million to provide over 500,000 meals to families in need. Throughout the month of July, Grocery Outlet customers, employees and store independent owner-operators across six states contributed food and monetary donations to help address critical food insecurity needs in their local communities.
More than 42.2 million Americans live without reliable access to affordable, nutritious food. In 2011 Grocery Outlet launched its first IFH campaign to help local food banks address high demand during the summer months. Deepening its commitment to helping address food insecurity in the communities it serves, Grocery Outlet set out this year to double the $524,414 raised in 2016’s IFH campaign. Grocery Outlet’s customers, employees and independent store operators stepped up to meet this bold fundraising challenge and raised $1,075,583. Local food banks will receive 100% of the proceeds as no administration or collateral fees will be deducted from the funds.
Read more on Business Insider →
Startup seeks to make vacation rentals more hotel-like
By Carolyn Said
A fast-growing Bay Area startup specializing in vacation rentals just landed a big round of venture capital backing. But it’s not Airbnb.
Emeryville’s RedAwning takes a different approach to home stays than the better-known San Francisco company. RedAwning focuses on helping property managers market their listings, process reservations and provide support such as a help center for their guests.
RedAwning works with Airbnb, as well as other big players like Expedia’s HomeAway/VRBO, Priceline’s Booking.com and TripAdvisor’s FlipKey. It inserts itself as another player between the guest and host (or property manager) to give vacation rentals the professional polish of a hotel stay.
Read More on SFChronicle.com →
Adamas Skyrockets on FDA Approval for Dyskinesia Treatment
The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson’s disease patients.
By Armie Margaret Lee
Shares of Adamas Pharmaceuticals Inc. (ADMS) soared 48.3% to $21.10 in premarket trading on Friday, Aug. 25, after the Emeryville, Calif.-based firm clinched the U.S. Food and Drug Administration’s approval for Gocovri as a treatment for dyskinesia in Parkinson’s disease patients receiving levodopa-based therapy, with or without concomitant dopaminergic medications.
In a news release after the market close on Thursday, Adamas said it expects that Gocovri will be available in the fourth quarter and formally launched with the full deployment of the company’s sales force in January 2018.
Read more on The Street →
This story and others made possible through the contributions of our supporters.